US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist
  • 1.590
  • -0.170-9.66%
Close Jul 22 16:00 ET
10.21MMarket Cap-193P/E (TTM)

Calidi Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
--1.14M
423.92%1.95M
423.92%1.95M
4,973.50%10.15M
--1.92M
-82.59%372K
-82.59%372K
--200K
408.81%2.14M
--2.14M
-Cash and cash equivalents
--1.14M
423.92%1.95M
423.92%1.95M
4,973.50%10.15M
--1.92M
-82.59%372K
-82.59%372K
--200K
408.81%2.14M
--2.14M
Receivables
--0
--1.36M
--1.36M
----
----
--0
--0
----
----
----
-Other receivables
----
--1.36M
--1.36M
----
----
----
----
----
----
----
Prepaid assets
--549K
592.79%769K
592.79%769K
----
----
--111K
--111K
----
----
----
Other current assets
--244K
-25.74%225K
-25.74%225K
492.31%1.54M
--890K
-49.75%303K
-49.75%303K
--260K
548.39%603K
--603K
Total current assets
--1.94M
447.46%4.3M
447.46%4.3M
2,440.65%11.69M
--2.81M
-71.31%786K
-71.31%786K
--460K
434.11%2.74M
--2.74M
Non current assets
Net PPE
--4.96M
391.99%5.34M
391.99%5.34M
442.40%5.46M
--5.73M
85.64%1.09M
85.64%1.09M
--1.01M
-19.09%585K
--585K
-Gross PPE
--6.05M
269.02%6.34M
269.02%6.34M
313.34%6.35M
--6.55M
76.10%1.72M
76.10%1.72M
--1.54M
-2.40%975K
--975K
-Accumulated depreciation
---1.09M
-57.37%-993K
-57.37%-993K
-68.11%-891K
---813K
-61.79%-631K
-61.79%-631K
---530K
-41.30%-390K
---390K
Financial assets
----
--230K
--230K
--1.29M
----
--0
--0
----
----
----
Other non current assets
--506K
-80.28%143K
-80.28%143K
-1.99%148K
--1.64M
998.48%725K
998.48%725K
--151K
-89.29%66K
--66K
Total non current assets
--5.47M
215.63%5.72M
215.63%5.72M
495.85%6.9M
--7.37M
178.19%1.81M
178.19%1.81M
--1.16M
-51.38%651K
--651K
Total assets
--7.41M
285.79%10.02M
285.79%10.02M
1,048.76%18.59M
--10.18M
-23.41%2.6M
-23.41%2.6M
--1.62M
83.10%3.39M
--3.39M
Liabilities
Current liabilities
Payables
--3.9M
26.68%2.88M
26.68%2.88M
-34.06%1.49M
--677K
263.94%2.27M
263.94%2.27M
--2.26M
-35.87%624K
--624K
-accounts payable
--3.81M
31.64%2.8M
31.64%2.8M
-33.30%1.41M
--596K
316.47%2.12M
316.47%2.12M
--2.11M
-37.96%510K
--510K
-Due to related parties current
--94K
-44.90%81K
-44.90%81K
-44.90%81K
--81K
28.95%147K
28.95%147K
--147K
-24.50%114K
--114K
Current accrued expenses
--3.29M
1.59%5.43M
1.59%5.43M
-41.99%2.97M
--6.9M
52.51%5.35M
52.51%5.35M
--5.12M
128.11%3.51M
--3.51M
Current debt and capital lease obligation
--5.39M
-65.30%1.92M
-65.30%1.92M
6.38%4.4M
--10.39M
7.84%5.54M
7.84%5.54M
--4.14M
-2.65%5.14M
--5.14M
-Current debt
--4.24M
-85.12%807K
-85.12%807K
-17.41%3.35M
--9.36M
8.46%5.43M
8.46%5.43M
--4.05M
1.21%5M
--5M
-Current capital lease obligation
--1.15M
862.07%1.12M
862.07%1.12M
1,113.79%1.06M
--1.03M
-14.71%116K
-14.71%116K
--87K
-59.52%136K
--136K
Other current liabilities
--567K
----
----
----
--42.67M
78.72%29.83M
78.72%29.83M
--24.21M
1,417.36%16.69M
--16.69M
Current liabilities
--14.95M
-76.20%10.23M
-76.20%10.23M
-69.57%10.87M
--60.63M
65.60%42.99M
65.60%42.99M
--35.73M
192.07%25.96M
--25.96M
Non current liabilities
Long term debt and capital lease obligation
--6.33M
1,088.59%5.31M
1,088.59%5.31M
2,364.98%5.35M
--3.66M
939.53%447K
939.53%447K
--217K
-99.33%43K
--43K
-Long term debt
--3.38M
--2.06M
--2.06M
--1.95M
----
----
----
----
----
----
-Long term capital lease obligation
--2.95M
627.74%3.25M
627.74%3.25M
1,464.52%3.4M
--3.66M
939.53%447K
939.53%447K
--217K
-40.28%43K
--43K
Derivative product liabilities
--697K
--671K
--671K
--2.95M
----
--0
--0
----
----
----
Preferred securities outside stock equity
----
--0
--0
--0
--9.6M
6.67%9.6M
6.67%9.6M
--9.6M
0.00%9M
--9M
Other non current liabilities
----
--2.04M
--2.04M
--508K
----
----
----
----
----
----
Total non current liabilities
--7.03M
-20.16%8.02M
-20.16%8.02M
-10.29%8.81M
--13.26M
11.10%10.05M
11.10%10.05M
--9.82M
-41.44%9.04M
--9.04M
Total liabilities
--21.98M
-65.58%18.25M
-65.58%18.25M
-56.79%19.68M
--73.89M
51.52%53.04M
51.52%53.04M
--45.54M
43.86%35M
--35M
Shareholders'equity
Share capital
--4K
100.00%4K
100.00%4K
100.00%4K
--2K
0.00%2K
0.00%2K
--2K
0.00%2K
--2K
-common stock
--4K
100.00%4K
100.00%4K
100.00%4K
--2K
0.00%2K
0.00%2K
--2K
0.00%2K
--2K
Retained earnings
---106.8M
-41.53%-99.57M
-41.53%-99.57M
-45.92%-91.34M
---89.32M
-56.59%-70.36M
-56.59%-70.36M
---62.6M
-30.47%-44.93M
---44.93M
Paid-in capital
--92.21M
358.55%91.38M
358.55%91.38M
382.54%90.25M
--25.63M
49.65%19.93M
49.65%19.93M
--18.7M
11.44%13.32M
--13.32M
Gains losses not affecting retained earnings
--11K
-235.71%-47K
-235.71%-47K
87.10%-4K
---17K
-1,300.00%-14K
-1,300.00%-14K
---31K
-116.67%-1K
---1K
Total stockholders'equity
---14.57M
83.67%-8.24M
83.67%-8.24M
97.51%-1.09M
---63.71M
-59.56%-50.44M
-59.56%-50.44M
---43.93M
-40.62%-31.61M
---31.61M
Total equity
---14.57M
83.67%-8.24M
83.67%-8.24M
97.51%-1.09M
---63.71M
-59.56%-50.44M
-59.56%-50.44M
---43.93M
-40.62%-31.61M
---31.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments --1.14M423.92%1.95M423.92%1.95M4,973.50%10.15M--1.92M-82.59%372K-82.59%372K--200K408.81%2.14M--2.14M
-Cash and cash equivalents --1.14M423.92%1.95M423.92%1.95M4,973.50%10.15M--1.92M-82.59%372K-82.59%372K--200K408.81%2.14M--2.14M
Receivables --0--1.36M--1.36M----------0--0------------
-Other receivables ------1.36M--1.36M----------------------------
Prepaid assets --549K592.79%769K592.79%769K----------111K--111K------------
Other current assets --244K-25.74%225K-25.74%225K492.31%1.54M--890K-49.75%303K-49.75%303K--260K548.39%603K--603K
Total current assets --1.94M447.46%4.3M447.46%4.3M2,440.65%11.69M--2.81M-71.31%786K-71.31%786K--460K434.11%2.74M--2.74M
Non current assets
Net PPE --4.96M391.99%5.34M391.99%5.34M442.40%5.46M--5.73M85.64%1.09M85.64%1.09M--1.01M-19.09%585K--585K
-Gross PPE --6.05M269.02%6.34M269.02%6.34M313.34%6.35M--6.55M76.10%1.72M76.10%1.72M--1.54M-2.40%975K--975K
-Accumulated depreciation ---1.09M-57.37%-993K-57.37%-993K-68.11%-891K---813K-61.79%-631K-61.79%-631K---530K-41.30%-390K---390K
Financial assets ------230K--230K--1.29M------0--0------------
Other non current assets --506K-80.28%143K-80.28%143K-1.99%148K--1.64M998.48%725K998.48%725K--151K-89.29%66K--66K
Total non current assets --5.47M215.63%5.72M215.63%5.72M495.85%6.9M--7.37M178.19%1.81M178.19%1.81M--1.16M-51.38%651K--651K
Total assets --7.41M285.79%10.02M285.79%10.02M1,048.76%18.59M--10.18M-23.41%2.6M-23.41%2.6M--1.62M83.10%3.39M--3.39M
Liabilities
Current liabilities
Payables --3.9M26.68%2.88M26.68%2.88M-34.06%1.49M--677K263.94%2.27M263.94%2.27M--2.26M-35.87%624K--624K
-accounts payable --3.81M31.64%2.8M31.64%2.8M-33.30%1.41M--596K316.47%2.12M316.47%2.12M--2.11M-37.96%510K--510K
-Due to related parties current --94K-44.90%81K-44.90%81K-44.90%81K--81K28.95%147K28.95%147K--147K-24.50%114K--114K
Current accrued expenses --3.29M1.59%5.43M1.59%5.43M-41.99%2.97M--6.9M52.51%5.35M52.51%5.35M--5.12M128.11%3.51M--3.51M
Current debt and capital lease obligation --5.39M-65.30%1.92M-65.30%1.92M6.38%4.4M--10.39M7.84%5.54M7.84%5.54M--4.14M-2.65%5.14M--5.14M
-Current debt --4.24M-85.12%807K-85.12%807K-17.41%3.35M--9.36M8.46%5.43M8.46%5.43M--4.05M1.21%5M--5M
-Current capital lease obligation --1.15M862.07%1.12M862.07%1.12M1,113.79%1.06M--1.03M-14.71%116K-14.71%116K--87K-59.52%136K--136K
Other current liabilities --567K--------------42.67M78.72%29.83M78.72%29.83M--24.21M1,417.36%16.69M--16.69M
Current liabilities --14.95M-76.20%10.23M-76.20%10.23M-69.57%10.87M--60.63M65.60%42.99M65.60%42.99M--35.73M192.07%25.96M--25.96M
Non current liabilities
Long term debt and capital lease obligation --6.33M1,088.59%5.31M1,088.59%5.31M2,364.98%5.35M--3.66M939.53%447K939.53%447K--217K-99.33%43K--43K
-Long term debt --3.38M--2.06M--2.06M--1.95M------------------------
-Long term capital lease obligation --2.95M627.74%3.25M627.74%3.25M1,464.52%3.4M--3.66M939.53%447K939.53%447K--217K-40.28%43K--43K
Derivative product liabilities --697K--671K--671K--2.95M------0--0------------
Preferred securities outside stock equity ------0--0--0--9.6M6.67%9.6M6.67%9.6M--9.6M0.00%9M--9M
Other non current liabilities ------2.04M--2.04M--508K------------------------
Total non current liabilities --7.03M-20.16%8.02M-20.16%8.02M-10.29%8.81M--13.26M11.10%10.05M11.10%10.05M--9.82M-41.44%9.04M--9.04M
Total liabilities --21.98M-65.58%18.25M-65.58%18.25M-56.79%19.68M--73.89M51.52%53.04M51.52%53.04M--45.54M43.86%35M--35M
Shareholders'equity
Share capital --4K100.00%4K100.00%4K100.00%4K--2K0.00%2K0.00%2K--2K0.00%2K--2K
-common stock --4K100.00%4K100.00%4K100.00%4K--2K0.00%2K0.00%2K--2K0.00%2K--2K
Retained earnings ---106.8M-41.53%-99.57M-41.53%-99.57M-45.92%-91.34M---89.32M-56.59%-70.36M-56.59%-70.36M---62.6M-30.47%-44.93M---44.93M
Paid-in capital --92.21M358.55%91.38M358.55%91.38M382.54%90.25M--25.63M49.65%19.93M49.65%19.93M--18.7M11.44%13.32M--13.32M
Gains losses not affecting retained earnings --11K-235.71%-47K-235.71%-47K87.10%-4K---17K-1,300.00%-14K-1,300.00%-14K---31K-116.67%-1K---1K
Total stockholders'equity ---14.57M83.67%-8.24M83.67%-8.24M97.51%-1.09M---63.71M-59.56%-50.44M-59.56%-50.44M---43.93M-40.62%-31.61M---31.61M
Total equity ---14.57M83.67%-8.24M83.67%-8.24M97.51%-1.09M---63.71M-59.56%-50.44M-59.56%-50.44M---43.93M-40.62%-31.61M---31.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg